BRS Results to Date: Imaging, Randomized Trials, and Anticipation of ABSORB III

Presentation TCT 2015

Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Slow Down, Excess Bleeding, and No Mortality Benefit? Primum Non Nocere and Save Costs!

Presenter: Tullio Palmerini

October 11, 2015

Presentation TCT 2015

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Presenter: Andrej Schmidt

October 11, 2015